09331486 · Active · incorporated 11 years, 8 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Medical Devices Series B+
Develops Chimeric Antigen Receptor T-Cell (CAR-T) therapies for the treatment of solid tumours.
See the complete cap table with every shareholder, founder tags, dilution across 20 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.